Skip to content
April 18, 2024

Equity.Guru

Investment information for the new generation

Search

pharmacokinetic study

Cybin’s (CYBN.NE) subsidiary Adelia Therapeutics completed earnout milestones originally set in a contribution agreement for the period of January 1, 2021, following Cybin’s acquisition of Adelia. There are a…
The Green Organic Dutchman (TGOD.T) and Caliper Foods have finished a human pharmacokinetic (PH) study for Caliper CBD, Caliper’s tasteless and odourless water-soluble powder that can be added to…